Does your toddler have a peanut allergy?
If your child has or may have a peanut allergy, we ask you to consider the COMFORT Toddlers study. It may help us learn more about treating peanut allergy in toddlers.
-
-
How to Report Food Label Issues for Food Allergies
If you or a loved one live with a food allergy, then you know the importance of reading food labels. Food labels identify the ingredients in your food. They also highlight if common allergens are present. What can you do if you have a severe allergic reaction to a food you thought was “safe” based…
-
Struggling to manage chronic urticaria symptoms (hives)?
Consider enrolling in the BLU-808-1201 clinical research study. You may qualify if you have chronic spontaneous urticaria and are still experiencing symptoms such as hives even after taking antihistamines. Participation lasts at least 4 months and includes the following:
-
Allergy & Asthma Network Applauds Congressional Funding for the National Asthma Control Program
Allergy & Asthma Network applauds Congress for approving funding for the CDC’s National Asthma Control Program.
-
Allergy & Asthma Day Capitol Hill: Join Us May 6
You are invited to attend the 29th annual Allergy & Asthma Day Capitol Hill (AADCH) advocacy day on Wednesday, May 6 in Washington, DC. Join fellow advocates to meet with members of Congress and their staff, and lend your voice on behalf of millions of people living with asthma, allergies and related conditions in the…
-
Understanding the New Childhood Vaccine Guidelines
By Nissa Shaffi, Director of Advocacy, Allergy & Asthma Network In January 2026, the U.S. Department of Health and Human Services (HHS) and the U.S. Centers for Disease Control and Prevention (CDC) announced major changes to the childhood immunization schedule, reducing the number of recommended vaccines from 17 to 11. Current vaccine recommendations CDC now…
-
Severe and Uncontrolled Asthma: Tailoring Therapies for Complex Patients (New Webinar)
Join Us for a FREE Webinar | March 18, 2026 | 1 PM ET Despite advances in treatment, many patients with asthma remain uncontrolled, experiencing frequent exacerbations, persistent symptoms, and reduced quality of life. Managing severe and uncontrolled asthma requires a personalized, evidence-based approach that accounts for disease heterogeneity, comorbidities, and patient-specific factors. Join us…
-
Allergy & Asthma Network Supports Proposed Funding for National Asthma Control Program
Allergy & Asthma Network is concerned about the impact on patients as the pandemic-era Affordable Care Act premium subsidies are set to expire.
-
USDA Updates Dietary Guidelines to Include Introduction of Food Allergens
Updated USDA Dietary Guidelines recommend introduction of potential food allergens to children in the first year of life.
-
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Shared Decision-Making Approach for Patients and Providers (New Webinar)
Join Us for a Free webinar | March 12, 2026 | 12 PM ET Do you experience ongoing sinus symptoms such as nasal congestion, facial pressure, sinus pain, or loss of smell? If these symptoms don’t improve, they may be caused by nasal polyps or chronic rhinosinusitis with nasal polyps (CRSwNP), a chronic inflammatory sinus…
-
Allergy & Asthma Network Launches National Patient Advocacy Leadership Initiative (PALI)
New program empowers patients and caregivers to influence healthcare policy and drive meaningful change. FAIRFAX, VA, JAN. 15, 2026 – Allergy & Asthma Network is proud to announce the launch of the Patient Advocacy Leadership Initiative (PALI). This multifaceted program is designed to build a nationwide network of informed, empowered patient advocates who are ready…
-
Depression and Anxiety in Patients with Asthma (New Webinar)
FREE Webinar | February 19, 2026 | 1 PM ET Depression and anxiety are common in patients with asthma and are frequently overlooked contributors to poor disease control, reduced treatment adherence, and diminished quality of life. Emerging evidence highlights the complex interactions between behavioral health, immune function, and respiratory disease. In this engaging webinar, we…
End of content
End of content
